These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 1662323)
21. Effect of dialysis on lipid metabolism in chronic renal failure - acetate versus bicarbonate. Kobayashi N; Okubo M; Marumo F; Nakamura H Int J Artif Organs; 1983 Jul; 6(4):187-90. PubMed ID: 6414954 [TBL] [Abstract][Full Text] [Related]
22. Lipid and apolipoproteins (ApoAI, ApoB, Apo CIII, ApoE) disturbance in hemodialysis (HD) and renal transplant (Tx) patients. Janicki K; Solski J; Janicka L; Kimak E; Bednarek-Skublewska A; Stettner S; Molas G Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):459-66. PubMed ID: 16146031 [TBL] [Abstract][Full Text] [Related]
23. Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis. Lazrak HH; René É; Elftouh N; Leblanc M; Lafrance JP BMC Nephrol; 2017 Jun; 18(1):187. PubMed ID: 28592259 [TBL] [Abstract][Full Text] [Related]
24. The safety of heparins in end-stage renal disease. Sonawane S; Kasbekar N; Berns JS Semin Dial; 2006; 19(4):305-10. PubMed ID: 16893408 [TBL] [Abstract][Full Text] [Related]
25. Effects of Flaxseed Oil on Serum Lipids and Lipoproteins in Hemodialysis Patients: a Randomized Controlled Trial. Mirfatahi M; Tabibi H; Nasrollahi A; Hedayati M Iran J Kidney Dis; 2016 Nov; 10(6):405-412. PubMed ID: 27904000 [TBL] [Abstract][Full Text] [Related]
26. Reduced lipid concentrations during four years of dialysis with low molecular weight heparin. Deuber HJ; Schulz W Kidney Int; 1991 Sep; 40(3):496-500. PubMed ID: 1664903 [TBL] [Abstract][Full Text] [Related]
28. [Assessment of malonyldialdehyde concentration as a product of lipid peroxidation and lipid metabolism in patients on chronic dialysis]. Miler M; Zamojska S; Fijałkowski P; Lobos M; Paradowski MT Pol Merkur Lekarski; 2006 Jun; 20(120):664-7. PubMed ID: 17007263 [TBL] [Abstract][Full Text] [Related]
29. Long-term effects on lipid metabolism of weight reduction on lactovegetarian and mixed diet. Marniemi J; Seppänen A; Hakala P Int J Obes; 1990 Feb; 14(2):113-25. PubMed ID: 2111292 [TBL] [Abstract][Full Text] [Related]
30. Effects of conventional heparin and low-molecular-weight heparin treatment on lipid metabolism during a single hemodialysis session. Camsari T; Cavdar C; Oztüre H; Onvural B; Semin I; Celik A; Kavukçu S Nephron; 1999; 82(3):286-8. PubMed ID: 10396006 [No Abstract] [Full Text] [Related]
31. Variations in the lipid profile of patients with chronic renal failure, treated with folic acid. de Gómez Dumm NT; Giammona AM; Touceda LA Int J Vitam Nutr Res; 2003 May; 73(3):215-20. PubMed ID: 12847999 [TBL] [Abstract][Full Text] [Related]
32. Apoprotein A and apoprotein B in patients with chronic renal failure undergoing hemodialysis and in renal graft recipients. Rubiés-Prat J; Romero R; Chacón P; Masdeu S; Griño J; Caralps A Nephron; 1983; 35(3):171-4. PubMed ID: 6355878 [TBL] [Abstract][Full Text] [Related]
33. Effect of unfractionated and low-molecular-weight heparin on OPG, sRANKL, and von Willebrand factor concentrations during hemodialysis. Klejna K; Naumnik B; Koc-Żórawska E; Myśliwiec M Clin Appl Thromb Hemost; 2014 May; 20(4):433-41. PubMed ID: 23104956 [TBL] [Abstract][Full Text] [Related]
34. Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients. Park JS; Jung HH; Yang WS; Kim SB; Min WK; Chi HS Nephrol Dial Transplant; 2000 Nov; 15(11):1835-40. PubMed ID: 11071974 [TBL] [Abstract][Full Text] [Related]
38. Acute lipidemic effect of calcium heparin in normolipemic and hyperlipemic subjects. Ferlito S; Ricceri M; Ossino AM Int Angiol; 1989; 8(3):140-4. PubMed ID: 2592796 [TBL] [Abstract][Full Text] [Related]
39. Influence of various heparin preparations on lipoproteins in hemodialysis patients: a multicentre study. Kronenberg F; König P; Neyer U; Auinger M; Pribasnig A; Meisl T; Pinter G; Dieplinger H Thromb Haemost; 1995 Oct; 74(4):1025-8. PubMed ID: 8560405 [TBL] [Abstract][Full Text] [Related]
40. Effects of heparin and dalteparin on oxidative stress during hemodialysis in patients with end-stage renal disease. Nassiri AA; Hakemi MS; Soulati M; Marashian M; Rahbar K; Azizi F Iran J Kidney Dis; 2009 Jul; 3(3):162-7. PubMed ID: 19617666 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]